The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
The world’s first dedicated hypotony clinic, funded by Moorfields Eye Charity, has been established at the Moorfields Eye ...
Nanoscope has received a new patent ( US Patent No. 12459977) from the US Patent and Trademark Office (USPTO) for the company ...
SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial ( ...
“The non-invasive in vivo optical imaging of rhodopsin activation extends the diagnostic capability of ORG and may facilitate ...
Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...
The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...
Their conversation focuses on anatomy-driven, individualized approaches and multidisciplinary decision-making for patients ...
Panelists discuss how aflibercept 8 mg maintains a safety profile similar to 2 mg and how workflow, systemic risk, and ...
STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...
A large international study 1 published in the British Journal of Ophthalmology has extended the knowledge about monkeypox ...
Vessel density in the deep capillary plexus reflects disease activity and structural involvement in thyroid eye disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback